ENTX CIK: 1638097

Entera Bio Ltd.

  • Israel
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
25.3
FY22:
12.8
FY23:
11.3
FY24:
8.97
FY25:
15.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.66
FY22:
0.28
FY23:
0.51
FY24:
0.42
FY25:
0.70
Total assets
Change from FY21 to FY25
millions USD
FY21:
26.0
FY22:
13.1
FY23:
11.8
FY24:
9.39
FY25:
16.0

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
3.16
FY22:
1.34
FY23:
1.09
FY24:
1.18
FY25:
2.20
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.26
FY22:
0.03
FY23:
0.29
FY24:
0.13
FY25:
0.69
(positive)
Change from FY21 to FY25
millions USD
FY21:
22.6
FY22:
11.8
FY23:
10.4
FY24:
8.08
FY25:
13.1
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
26.0
FY22:
13.1
FY23:
11.8
FY24:
9.39
FY25:
16.0

All amounts in millions USD Data source:SEC EDGAR